POPULATION PHARMACOKINETIC ANALYSIS OF THE SUBLINGUAL FILM FORMULATION OF DEXMEDETOMIDINE (BXCL501) IN HEALTHY VOLUNTEERS AND ADULTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER

被引：0

作者：

Lagraauw, H. ^{[1
]}

Adedoyin, A. ^{[2
]}

Lathia, C. ^{[2
]}

Lindbom, L. ^{[3
]}

Jonsson, F. ^{[3
]}

机构：

[1] qPharmetra, Njimegen, Netherlands

[2] BioXcel Therapeut, New Haven, CT USA

[3] qPharmetra, Stockholm, Sweden

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PII-100

引用

页码：S74 / S74

页数：1

共 8 条

[1] LONGITUDINAL EFFICACY ANALYSIS OF THE SUBLINGUAL FILM FORMULATION OF DEXMEDETOMIDINE (BXCL501) FOR THE TREATMENT OF ACUTE AGITATION ASSOCIATED WITH SCHIZOPHRENIAAND BIPOLAR DISORDER
Jonsson, F.
Lagraauw, H.
Lathia, C.
Adedoyin, A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S56 - S56
[2] Pharmacokinetics of dexmedetomidine after a single sublingual dose of BXCL501 in patients with agitation associated with schizophrenia
Adedoyin, Adedayo
Preskorn, Sheldon
Lathia, Chetan
BIPOLAR DISORDERS, 2021, 23 : 84 - 84
[3] Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson's disease
Agbo, Felix
Crass, Ryan L.
Chiu, Yu-Yuan
Chapel, Sunny
Galluppi, Gerald
Blum, David
Navia, Bradford
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (04): : 1464 - 1475
[4] A Population Pharmacokinetic Analysis of Budesonide Oral Suspension in Children and Adults With Eosinophilic Esophagitis and Healthy Adult Volunteers
Song, Ivy H.
Rodgers, Trudy
Hayes, Siobhan
Farrell, Colm
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S220 - S220
[5] Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Citrome, Leslie
Risinger, Robert
Rajachandran, Lavanya
Robison, Heather
ADVANCES IN THERAPY, 2022, 39 (10) : 4821 - 4835
[6] Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Leslie Citrome
Robert Risinger
Lavanya Rajachandran
Heather Robison
Advances in Therapy, 2022, 39 : 4821 - 4835
[7] Correction to: Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Leslie Citrome
Robert Risinger
Lavanya Rajachandran
Heather Robison
Advances in Therapy, 2023, 40 : 391 - 391
[8] Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed (vol 38, pg 4821, 2022)
Citrome, Leslie
Risinger, Robert
Rajachandran, Lavanya
Robison, Heather
ADVANCES IN THERAPY, 2023, 40 (01) : 391 - 391

← 1 →